menu
    • menu

    Company profile for Pear Therapeutics

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurolog...
    Pear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. We operate at the intersection of biology and software technology, where researchers and clinicians work side-by-side with software engineers and developers to create the next generation of therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pear TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    BOSTON 200 STATE STREET BOSTON, MA 02109
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://peartherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pear-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Pear_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shunned by insurers, digital therapeutics startups look for ways to get paid
    Shunned by insurers, digital therapeutics startups look for ways to get paid

    02 Jan 2024

    // Ngai Yeung ENDPTS

    https://endpts.com/shunned-by-insurers-digital-therapeutics-startups-look-for-other-ways-to-get-paid/

    Ngai Yeung ENDPTS
    02 Jan 2024
    Share Share
    Nox Health Closes Acquisition of Somryst, the Only FDA Pear Therapeutics
    Nox Health Closes Acquisition of Somryst, the Only FDA Pear Therapeutics

    20 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/20/2691426/0/en/Nox-Health-Closes-Acquisition-of-Somryst-the-Only-FDA-Cleared-Digital-Insomnia-Treatment-From-Pear-Therapeutics.html

    GLOBENEWSWIRE
    20 Jun 2023
    Share Share
    Pear Therapeutics apps sell for $6M in post-bankruptcy auction
    Pear Therapeutics apps sell for $6M in post-bankruptcy auction

    19 May 2023

    // Andrea Park FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/pear-pulped-digital-therapeutics-makers-assets-sold-6m-auction-after-bankruptcy-filing

    Andrea Park FIERCE BIOTECH
    19 May 2023
    Share Share
    Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers
    Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers

    11 Apr 2023

    // Amber Tong ENDPTS

    https://endpts.com/digital-therapeutics-maker-pear-files-for-bankruptcy-lays-off-170-staffers-including-ceo/

    Amber Tong ENDPTS
    11 Apr 2023
    Share Share
    Pear Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process
    Pear Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process

    07 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230407005087/en

    BUSINESSWIRE
    07 Apr 2023
    Share Share
    Pear Tx files for bankruptcy, will seek to sell assets
    Pear Tx files for bankruptcy, will seek to sell assets

    07 Apr 2023

    // PHARMAPHORUM

    https://pharmaphorum.com/news/pear-tx-files-bankruptcy-will-seek-sell-assets

    PHARMAPHORUM
    07 Apr 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search